Yes, thanks very much, Mr. Chair.
Thanks to all our witnesses. I wish I had half an hour to question you all. You're giving a lot of depth to your presentations. I only have five minutes, though, and I'm splitting it with Ms. Malcolmson.
Mr. Sanger, that was a very interesting presentation. We know already that in terms of competitive advantages, our universal health care system has a competitive advantage of about $3,000 a year per employee. A Canadian company doesn't have to pay that cost. An American company does. That is a major advantage to any Canadian company.
I understand from your presentation that you're talking about child care and pharmacare as further investments that should be made to improve the competitiveness of Canadian companies, including that $4.5 billion that would be taken off the books of Canadian companies and assumed through a universal pharmacare plan.
You raised the issue around e-commerce companies and the fact that they are getting off the hook from paying a wide range of taxes and obligations that Canadian companies have. You also raised the issue around the $700 billion basically being parked—dead money—with that surprising statistic that as tax cuts have kicked in for the corporate sector over the last 20 years, business investment in machinery and equipment has actually declined.
These are, I think, surprising and important things for the committee to note. Could you add anything in terms of what this committee needs to consider before we put forward our recommendations in the pre-budget report?